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Background: Cardiac magnetic resonance (CMR) myocardial perfusion imaging has been suggested as a
non-invasive alternative to pressure wire guided fractional flow reserve (FFR) in detecting haemodynamically
significant obstructive coronary artery disease (CAD). The objective of this systematic review is to determine the
diagnostic accuracy of CMR and to compare it to FFR.
Methods/design: A systematic review of diagnostic test accuracy of CMR and FFR will be conducted. Relevant
English-language articles published before November 2013 in Medline, PubMed, EMBASE, Google scholar, Scopus
and Cochrane databases will be identified. Relevant referenced articles from those selected will also be analysed.
Articles describing diagnostic studies that compared CMR to FFR in patients with known or suspected coronary
artery disease will be included. Two investigators will independently screen, assess quality and extract data from the
selected articles. The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool will be used to assess
methodological quality. STATA 13 (the xtmelogit command) software will be used to calculate bivariate random
effects models and estimate pooled sensitivity and specificity with 95% confidence intervals. Forests plots and
summary receiver operating characteristics curves will also be generated. Sub-group pooled analyses using image quality
of CMR (in terms of magnetic flux density - Tesla) and basis of analyses (coronary arterial territory vs. patients basis)
at different FFR cutoffs (≤0.75 and ≤0.8) will also be performed.
Discussion: This systematic review will help to determine if CMR is an adequate alternative to FFR in the diagnosis
of significant and obstructive CAD. We will also be able to assess diagnostic accuracy of specific types of CMR scan
at different FFR cutoffs.
Systematic review registration: This systematic review had been registered at PROSPERO and the registration
number is CRD42013006180.
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Ischaemic heart disease (IHD) as a consequence of un-
treated coronary artery disease (CAD) is one of the top
three causes of mortality and the most common cause
of morbidity in developed countries [1,2]. Therefore,
early diagnosis is important. Assessment of haemo-
dynamically significant narrowing of coronary arteries
with pressure-wire guided fractional flow reserve (FFR)
is a widely accepted practice by interventional cardiologists
[3-6]. However, this technique is invasive and exposes pa-
tients to ionizing radiation. Hence, the use of non-invasive
diagnostic tools with less or no radiation is desirable.
Cardiac magnetic resonance (CMR) perfusion imaging
is a well-established and non-invasive technique that has
been shown to be safe in the diagnosis of obstructive cor-
onary lesions [7]. In a single exam, both anatomical and
functional information can be integrated with high spatial
and temporal resolution without exposing the patient to
harmful radiation [8].
Several small individual studies have evaluated the
diagnostic performance of CMR compared to FFR,
with its diagnostic power varying among reports. Some
of these studies have been included in a meta-analyses
which compared CMR to quantitative coronary angi-
ography (QCA) [9]. As several reports have been pub-
lished after the above meta-analyses [10-13], and also
owing to the fact that QCA often provides insufficient
information regarding physiological significance of the
coronary lesions, an updated systematic review of CMR
diagnostic accuracy compared with an invasive pressure-
wire guided FFR is required.
The primary objective is to assess the diagnostic ac-
curacy of CMR perfusion imaging in the detection of
functionally significant, obstructive coronary artery
lesions in patients with known or suspected CAD, in
comparison to FFR.
The secondary objective is to assess the potentially
relevant-patient benefit (prognosis) of CMR perfusion
imaging in the diagnosis of haemodynamically signifi-
cant, obstructive but stable CAD. We also plan to in-
vestigate the diagnostic accuracy of CMR on the basis
of magnetic flux density (in Tesla) and basis of analysis
(coronary artery territory vs. patient analysis) and the
methodological quality of the included studies.
Methods/Design
Design
The design of this systematic review follows the meth-
odological approach as recommended by the Cochrane
collaboration methods group on screening and diagnos-
tic tests [14], the Agency for Healthcare Research and
Quality and the United Kingdom National Institute for
Health and Clinical Excellence. This protocol was writ-
ten in accordance with the preferred reporting itemsfor systematic review and meta-analysis (PRISMA) [15].
This protocol has also been registered with PROSPERO
(#CRD42013006180).
Search strategy
Relevant original English-language articles published prior
to November 2013 in OVID Medline, Cochrane, Embase,
Scopus, Google Scholar and PubMed databases will be elec-
tronically searched. Reference lists of all the retrieved pa-
pers will also be extensively cross-checked to supplement
the list of the selected articles. Details of the specific search
strategies for the relevant databases are shown in Additional
file 1 (search strategy for OVID Medline database) and
Additional file 2 (search strategy for PubMed Database).
Eligibility criteria and study selection
Search terms are present either in the title or abstract
for the articles to be considered for analysis. Studies se-
lected for inclusion are those which evaluate the diagnos-
tic accuracy of CMR perfusion imaging (index test) for the
detection of functionally significant coronary artery lesions
(target condition) compared to an appropriate reference
standard. The reference standard which will be used is
coronary angiogram guided pressure wire-derived FFR.
An FFR cutoff of either <0.75 or ≤0.80 will be used. These
cutoffs are used because they include the narrow ‘grey
zone’ (0.75-0.80) associated with inducible myocardial
ischaemia with accuracy of ≤0.75 being above 90% [16].
An FFR cutoff of ≤0.80 has widely been used in multi-
vessel CAD since its introduction by the FAME investiga-
tors [17]. The two cutoffs are still used interchangeably by
researchers at this point.
Other forms of reference standard, such as single photon
emission computed tomography (SPECT), visual coronary
angiogram alone, stress echocardiogram and electrocardio-
gram or computed tomography coronary angiogram, will
not be included so as to avoid verification bias [18]. Two re-
viewers will independently screen the titles and the ab-
stracts to deem a study suitable for inclusion. Subsequently,
the entire manuscript will be assessed by one reviewer and
double checked by another. Disagreements will be resolved
by consensus or referral to a third reviewer. Review articles
(to avoid repeated data), unpublished studies, letters, com-
ments and case reports will be excluded.
Data selection
Eligible articles, fulfilling our inclusion criteria, will be
independently reviewed by two authors. The data to be
extracted will include the author, country, year of publi-
cation, number and age of subjects, type of study, either
single or multi-vessel CAD, diagnostic test characteris-
tics and threshold for critical functional coronary arterial
luminal stenosis (FFR ≤0.75 and or ≤0.8). Where values are
not available we will also manually extract and calculate
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negative (TN), false negative (FN), sensitivity, specificity,
accuracy, positive predictive value, negative predictive
value, positive likelihood ratio and negative likelihood
ratio results in the detection of haemodynamically
significant obstructive coronary artery lesions. Data for
the diagnostic performance of CMR perfusion imaging
against FFR will be displayed in contingency 2 × 2 tables.
In order to allow the calculation of outcomes measures
of interest, empty cells will be filled with 0.5 of events.
Assessment of methodological quality
Two reviewers will independently assess methodo-
logical quality of included studies by using the pub-
lished QUADAS-2 (the Quality Assessment of Diagnostic
Accuracy studies) tool [19]. CMR results should be inter-
preted without knowledge of FFR. The QUADAS-2 tool
was chosen because it assesses the risk of bias by meth-
odological domain (participant selection, index test, refer-
ence standard and flow of participant through the study
(see Additional file 3) rather than the more general
overall risk of bias - as evident in the original QUADAS.
The agreement or disagreement between the reviewers
(inter-rater reliability) in evaluating methodological quality
will be calculated with Cohen Kappa coefficient (k) [20].
The items in QUADAS-2 will be as recommended by the
Cochrane collaboration methods group on screening and
diagnostic tests [14], the Agency for Healthcare Research
and Quality and the United Kingdom National Institute for
Health and Clinical Excellence. This tool will be applied in
four phases: (1) the review question will be summarised;
(2) the tool will be tailored to produce a review-specific
guidance; (3) a flow diagram for the primary study will
be constructed; and finally (4) bias and applicability
will be judged. See Additional file 3 which shows an
adapted QUADAS-2 in assessment of the risk of bias
and applicability.
Outcomes
The primary outcome of this systematic review is to as-
sess the diagnostic accuracy of CMR perfusion imaging
in the detection of functionally significant obstructive
luminal stenoses in patients with known or suspected
CAD in comparison to FFR. The secondary objectives
are to investigate the diagnostic accuracy of CMR in
the diagnosis of haemodynamically obstructive CAD on the
basis of magnetic flux density (defined in Tesla) and basis
of analysis (coronary artery territory vs. patient basis).
We will also be able to assess the methodological quality
of the included studies.
Statistical analysis and data synthesis
Data analysis will be performed according to the following
steps: (1) inter-rater reliability testing for study selectionand assessment of methodological quality; (2) calcula-
tion of test accuracy measures (sensitivity, specificity
and likelihood ratios); (3) testing of heterogeneity; (4)
pooling of data; and (5) sub-group analysis.
Agreement between the reviewers (inter-rater reliability)
in evaluating methodological quality by using the revised
QUADAS-2 tool will be calculated with Cohen Kappa
coefficient (k) [20]. QUADAS-2 suggested tabulations
[19] will also be used to present assessment results of
overall performance of the selected studies. We will also
calculate the sensitivity, specificity, positive and negative
likelihood ratio (LR) and the diagnostic odds ratio (DOR)
along with 95% confidence intervals (CI) to determine the
diagnostic accuracy of each index test in differentiating
non-significant from significant and haemodynamically
critical coronary arterial luminal stenosis.
To statistically determine the heterogeneity in the studies
we will use Cochrane Q (x2 statistic) test and the I2 statistic
for heterogeneity. Evidence of clinically relevant heterogen-
eity will be considered when the I2 statistic is >25% [21].
In cases where clinically relevant heterogeneity is found,
outcome measures will be estimated from studies factoring
the highest scientific validity (studies that are most likely to
be free from bias). Using bivariate random effects model
(BREM), pooled and individual estimates of sensitivity and
specificity at 95% CI will be presented in forest-plot dia-
grams. We will also generate summary of receiver operator
curves (SROC) using point estimates of each study as well
as symmetrical summary curve, a summary point estimate,
95% confidence region and 95% prediction region using
STATA version 13 (xtmelogit command) as it has the cap-
abilities [22]. We also intend to use multivariate random
effects model in the calculation pooled analysis of CMR’s
diagnostic accuracy in relation to different FFR thresholds
[23]. Direct comparison of CMR and FFR will also be
achieved by using bivariate models.
We will evaluate the presence of possible publication
bias graphically by drawing funnel plots for each outcome
measure and statistically by means of Egger’s standard
regression test. Two-tailed P <0.10 tests will be assumed
to be statistically significant. We will also acknowledge
methodological heterogeneity or true study heterogen-
eity as these could also introduce asymmetry in publica-
tion bias assessment [24]. The bivariate random effects
model was preferred for this protocol as it preserves the
two-dimensional nature of the original data. It also allows
the estimation of between study variation in sensitivity and
specificity separately in addition to the degree of correlation
between the two [25].
Discussion
The assessment of the haemodynamic clinical relevance
of coronary arterial lesions seen on routine qualitative
coronary angiography is important as evidence has
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benefit for routine revascularisation procedures in patients
with stable coronary disease [26]. Conversely, there is evi-
dence for improved outcomes following revascularisation
in subjects with known haemodynamically significant cor-
onary artery lesions [3-6]. Previous diagnostic test studies
comparing CMR and FFR have reported variable results.
Whether this is due to imprecision in reporting or variable
methodological quality it is still not clear and needs to be
explored. This systematic review will allow determination
as to whether CMR is an adequate screening test in the
diagnosis of significant obstructive CAD. It will also deter-
mine if CMR could replace FFR for diagnosing coronary
arterial lesions that are haemodynamically significant, and
allow consideration of the potential benefit of CMR in
diagnosing ischaemic [27] and non-ischaemic myocardial
pathologies [28-30] without exposing patients to ionising
radiation. This systematic review may also identify the type
of CMR magnetic field strength that could provide the
greatest sensitivity and specificity. The results of the review
will be communicated as abstract presentations at confer-
ences and will be published in a peer-reviewed journal.Additional files
Additional file 1: The search strategy for OVID MedLine.
Additional file 2: The search strategy used in PubMed Database.
Additional file 3: Risk of bias and applicability judgements in
QUADAS-2.Abbreviations
AUC: Area under the curve; CAD: Coronary artery disease; CMR: Cardiac
magnetic resonance; FFR: Fractional flow reserve; LR: Likelihood ratio;
SROC: Summary of receiver operator curves; QUADAS: Quality assessment of
diagnostic accuracy studies.
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